EQRx Stock

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery.

About EQRx Stock

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. EQRx was founded in 2019 and is based in Cambridge, Massachusetts, United States.

Funding History

January 2020	$200M

Management

Co-Founder

Peter Bach

Co-Founder

Sandra Horning

Other Companies

Learn More

Genomic Health

Genomic Health is a provider of genomic-based diagnostic tests that address overtreatment and optimal treatment of early-stage cancer.

Lodo Therapeutics is a drug discovery and development company.

personalized cancer treatment

13Age (years)

$74.5MTotal Funding

Learn More

Precision BioSciences

Precision BioSciences is a biotechnology company dedicated to improving life.

16Age (years)

$175MTotal Funding

Learn More

Thrive Earlier Detection

Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care.

2Age (years)

$367MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from EQRx or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.